Cargando…
Synthesis, In vitro Antifungal and Antitumour Activity of Some Triorganotin(IV) N,C,N-Chelates
The in vitro antifungal activity of compounds 1-3 ([Formula: see text] [Formula: see text]; (where X=Cl, R=n-Bu for 1, X=Br, R=n-Bu for 2 and x= [Formula: see text] , R=n=Bu for 3)) was estimated with the help of a modified microdilution format of the M27-A guidelines and was compared with in vitro...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365299/ https://www.ncbi.nlm.nih.gov/pubmed/18475429 http://dx.doi.org/10.1155/MBD.2002.91 |
Sumario: | The in vitro antifungal activity of compounds 1-3 ([Formula: see text] [Formula: see text]; (where X=Cl, R=n-Bu for 1, X=Br, R=n-Bu for 2 and x= [Formula: see text] , R=n=Bu for 3)) was estimated with the help of a modified microdilution format of the M27-A guidelines and was compared with in vitro activity of their diphenyltin(IV) analogues 4 and 5 (where X=Br, R=Ph for 4 and X= [Formula: see text] , R=Ph for 5), and of drugs currently in clinical use (ketoconazole, fluconazole and amphotericin B). It was found that in coordinating solvents the more soluble derivative 2 is less active than the phenyl one (4), and compounds 1 and 3 are even inactive. In this paper, the in vitro antitumour activity of ionic diphenyltin(IV) complexes 4 and 5 against seven tumoural cell lines of human origin is also reported. The preparation and characterization ([Formula: see text] , [Formula: see text] and [Formula: see text] NMR spectroscopy and electrospray ionization mass spectrometry) of the novel compound 3 is mentioned too. |
---|